{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:38:09Z","timestamp":1788043089466,"version":"build-2784847793"},"reference-count":25,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Immunotherapies directed against B-cell surface markers have been a common developmental strategy to treat B-cell malignancies. The immunoglobulin heavy chain surrogate light chain (SLC), comprising the VpreB1 (CD179a) and Lamda5 (CD179b) subunits, is expressed on pro- and pre-B cells, where it governs pre\u2013B-cell receptor (BCR)-mediated autonomous survival signaling. We hypothesized that the pre-BCR might merit the development of targeted immunotherapies to decouple \u201cautonomous\u201d signaling in B-lineage acute lymphoblastic leukemia (B-ALL). We used the Children\u2019s Oncology Group (COG) minimal residual disease (MRD) flow panel to assess pre-BCR expression in 36 primary patient samples accrued to COG standard- and high-risk B-ALL studies through AALL03B1. We also assessed CD179a expression in 16 cases with day 29 end-induction samples, preselected to have \u22651% MRD. All analyses were performed on a 6-color Becton-Dickinson flow cytometer in a Clinical Laboratory Improvement Amendment\/College of American Pathologist\u2013certified laboratory. Among 36 cases tested, 32 cases were at the pre-B and 4 cases were at the pro-B stages of developmental arrest. One or both monoclonal antibodies (mAbs) showed that CD179a was present in \u226520% of the B-lymphoblast population. All cases expressed CD179a in the end-induction B-lymphoblast population. The CD179a component of the SLC is commonly expressed in B-ALL, regardless of genotype, stage of developmental arrest, or National Cancer Institute risk status.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005245","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T21:16:20Z","timestamp":1634764580000},"page":"585-589","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["VpreB surrogate light chain expression in B-lineage ALL: a report from the Children\u2019s Oncology Group"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3583-7727","authenticated-orcid":false,"given":"Stuart S.","family":"Winter","sequence":"first","affiliation":[{"name":"Cancer and Blood Disorders Program, Children\u2019s Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"McCaustland","sequence":"additional","affiliation":[{"name":"Children\u2019s Minnesota Core Laboratory, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxu","family":"Qu","sequence":"additional","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u2019eau","family":"Simeona","sequence":"additional","affiliation":[{"name":"Lawrence University LU.RI Summer Research Program, Appleton, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyla A.","family":"Heerema","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9844-730X","authenticated-orcid":false,"given":"Andrew J.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-3969","authenticated-orcid":false,"given":"Brent L.","family":"Wood","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Los Angeles, Los Angeles, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Gheorghe","sequence":"additional","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget S.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of New Mexico, Albuquerque, NM"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"2022011916244391200_B1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-800267-4.00004-3","article-title":"Signaling circuits in early B-cell development","volume":"122","author":"Reth","year":"2014","journal-title":"Adv Immunol."},{"issue":"456","key":"2022011916244391200_B2","doi-asserted-by":"crossref","first-page":"ra116","DOI":"10.1126\/scisignal.aaf3949","article-title":"Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia","volume":"9","author":"Erasmus","year":"2016","journal-title":"Sci Signal."},{"issue":"8","key":"2022011916244391200_B3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ni.1903","article-title":"N-linked glycosylation selectively regulates autonomous precursor BCR function","volume":"11","author":"Ubelhart","year":"2010","journal-title":"Nat Immunol."},{"issue":"1","key":"2022011916244391200_B4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/imr.12235","article-title":"Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia","volume":"263","author":"Buchner","year":"2015","journal-title":"Immunol Rev."},{"issue":"16","key":"2022011916244391200_B5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med."},{"issue":"11","key":"2022011916244391200_B6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJMoa1605085","article-title":"Rituximab in B-lineage adult acute lymphoblastic leukemia","volume":"375","author":"Maury","year":"2016","journal-title":"N Engl J Med."},{"issue":"9","key":"2022011916244391200_B7","doi-asserted-by":"crossref","first-page":"e0162638","DOI":"10.1371\/journal.pone.0162638","article-title":"The expression pattern of the pre-B cell receptor components correlates with cellular stage and clinical outcome in acute lymphoblastic leukemia","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One."},{"issue":"1","key":"2022011916244391200_B8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40266-017-0503-5","article-title":"Treatment of older patients with acute lymphoblastic leukaemia","volume":"35","author":"G\u00f6kbuget","year":"2018","journal-title":"Drugs Aging."},{"issue":"7686","key":"2022011916244391200_B9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature25167","article-title":"Senescence-associated reprogramming promotes cancer stemness","volume":"553","author":"Milanovic","year":"2018","journal-title":"Nature."},{"issue":"6","key":"2022011916244391200_B10","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/leu.2016.9","article-title":"Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K\/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition","volume":"30","author":"K\u00f6hrer","year":"2016","journal-title":"Leukemia."},{"issue":"24","key":"2022011916244391200_B11","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1182\/blood-2015-01-567842","article-title":"Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia","volume":"125","author":"M\u00fcschen","year":"2015","journal-title":"Blood."},{"issue":"8","key":"2022011916244391200_B12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1182\/blood-2015-03-633685","article-title":"Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children\u2019s Oncology Group study AALL0232","volume":"126","author":"Borowitz","year":"2015","journal-title":"Blood."},{"issue":"2","key":"2022011916244391200_B13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet."},{"issue":"8","key":"2022011916244391200_B14","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20090004","article-title":"Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function","volume":"206","author":"Trageser","year":"2009","journal-title":"J Exp Med."},{"issue":"20","key":"2022011916244391200_B15","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood."},{"issue":"11","key":"2022011916244391200_B16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/cyto.a.22736","article-title":"Compensation in multicolor flow cytometry","volume":"87","author":"Szal\u00f3ki","year":"2015","journal-title":"Cytometry A."},{"issue":"9","key":"2022011916244391200_B17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jclinpath-2018-205172","article-title":"Identification of early B cell precursors (stage 1 and 2 hematogones) in the peripheral blood","volume":"71","author":"Kurzer","year":"2018","journal-title":"J Clin Pathol."},{"issue":"1","key":"2022011916244391200_B18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1309\/LXU4-Q7Q9-3YAB-4QE0","article-title":"Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features","volume":"114","author":"Rimsza","year":"2000","journal-title":"Am J Clin Pathol."},{"issue":"3","key":"2022011916244391200_B19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ajcp\/110.3.313","article-title":"The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy","volume":"110","author":"Rimsza","year":"1998","journal-title":"Am J Clin Pathol."},{"key":"2022011916244391200_B20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/hematology.2019000018","article-title":"Mechanisms of and approaches to overcoming resistance to immunotherapy","volume":"2019","author":"Schultz","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"1","key":"2022011916244391200_B21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MOP.0000000000000866","article-title":"The future of cellular immunotherapy for childhood leukemia","volume":"32","author":"Bonifant","year":"2020","journal-title":"Curr Opin Pediatr."},{"issue":"5","key":"2022011916244391200_B22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0092-8674(92)90293-L","article-title":"A critical role of lambda 5 protein in B cell development","volume":"69","author":"Kitamura","year":"1992","journal-title":"Cell."},{"issue":"12","key":"2022011916244391200_B23","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.4049\/jimmunol.168.12.6286","article-title":"VpreB1\/VpreB2\/lambda 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus","volume":"168","author":"Shimizu","year":"2002","journal-title":"J Immunol."},{"issue":"6","key":"2022011916244391200_B24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0092-8674(91)90032-T","article-title":"Molecular and cellular origins of B lymphocyte diversity","volume":"66","author":"Rolink","year":"1991","journal-title":"Cell."},{"key":"2022011916244391200_B25","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.3389\/fimmu.2018.02423","article-title":"The role of the pre-B cell receptor in B cell development, repertoire selection, and tolerance","volume":"9","author":"Winkler","year":"2018","journal-title":"Front Immunol."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/2\/585\/1860728\/advancesadv2021005245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/2\/585\/1860728\/advancesadv2021005245.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T16:30:47Z","timestamp":1642609847000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/2\/585\/477380\/VpreB-surrogate-light-chain-expression-in-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005245","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]}}}